Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells
/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2018-05-22 / Oncol Lett 2018 Jul;16(1):1180-1188Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2018-05-17 / Oncol Lett 2018 Jul;16(1):1348-1356Vaccine therapy in hematologic malignancies
/in Dendritic Cells, International Publications /von 2018-05-04 / Blood 2018 Jun;131(24):2640-2650Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors
/in Dendritic Cells, International Publications /von 2018-05-01 / Vaccine 2018 05;36(23):3247-3253Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2018-05-01 / Ann. Oncol. 2018 May;29(5):1312-1319Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2018-04-26 / Front Oncol 2018;8:127Immunotherapy of Hepatocellular Carcinoma
/in Checkpoint-Inhibitors, Dendritic Cells, Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2018-04-20 / Oncol Res Treat 2018;41(5):292-297Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-04-11 / Sci Transl Med 2018 Apr;10(436)WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2018-04-01 / Anticancer Res. 2018 04;38(4):2217-2225
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de